The Medical Device Package Validation Market Size is predicted to grow at a 8.61% CAGR during the forecast period for 2024-2031. The whole process of packaging validation is the identification and management of materials and production factors influencing the capacity of a packaged product to satisfy acceptance criteria. Validation's outcomes provide various advantages. Process control and assurance are attained to fulfil the device package cr...
Report ID: 2701 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 175
The Hematological Malignancies Drugs Market Size is estimated to grow at a CAGR of 14.2% during the forecast period for 2024-2031. Hematologic malignancies are cancers that most often start in the bone marrow or the immune system cells. Lymphom, leukemia, and multiple myeloma are the three most common blood malignancies. The development of innovative agents has contributed to improved outcomes for cancer patients in recent years, re...
Report ID: 1211 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Long Read Sequencing Market Size is valued at USD 594.8 Mn in 2023 and is predicted to reach USD 4,571.3 Mn by the year 2031 at an 29.7% CAGR during the forecast period for 2024-2031. Long-read sequencing is an advanced DNA sequencing technology that allows researchers to read longer sequences of DNA, surpassing the capabilities of traditional short-read methods. This technology is essential for deciphering complex genomic structures and v...
Report ID: 2694 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 168
The Antibody Hit Generation and Screening Market Size is predicted to grow at an 9.78% CAGR during the forecast period for 2024-2031. Antibody hit generation and screening is a vital step in developing therapeutic antibodies, focusing on identifying and selecting candidates that bind to a target antigen with high affinity and specificity. This process leverages various technologies like hybridoma technology, phage display, yeast display, ribos...
Report ID: 2667 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 168
The Cell Line Characterization Market Size is valued at USD 378.96 Mn in 2023 and is predicted to reach USD 651.34 Mn by the year 2031 at an 7.25% CAGR during the forecast period for 2024-2031. Cell line characterization is crucial in developing and producing biologics, ensuring the identity, purity, and genetic stability of cell lines used in research and therapeutic applications. This process is essential for complying with regulatory standa...
Report ID: 2668 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 165
The Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size is valued at 6.72 billion in 2023 and is predicted to reach 17.32 Million by the year 2031 at a 12.62% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: Increasing adoption of advanced technologies, manual error reductions in drug development processes due to cloud-based applications, fast implem...
Report ID: 1026 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Ovarian Cancer Market is expected to grow at a 10.5% CAGR during the forecast period for 2024-2031. Ovarian cancer rank fifth in cancer deaths among women and accounting for more deaths than any other cancer of the female reproductive system. Previously it believed that cancer begin only in the ovaries, but recent evidence suggests that many ovarian cancer may start in the fallopian tubes. Factors can increase risk of cancer include ol...
Report ID: 1067 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Breast Cancer Market is expected to grow at an 8.8% CAGR during the forecast period for 2024-2031. Breast cancer start when cells in the breast begin to grow out of control. These cells form tumour that can often see on an x-ray. Breast cancer is the most common cancer among women, after skin cancer and second leading cause of cancer death in women after lung cancer. Breast cancer is broadly classified into two include non-invasive and...
Report ID: 1069 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 140
The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031. The services used by biopharmaceutical or pharmaceutical companies to conduct clinical trial either for the approval of a new drug or biologic or for the entry of new generic or biosimilar to the market is ...
Report ID: 1071 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Global Leptospirosis Market is expected to grow at a 6.0% CAGR during the forecast period for 2024-2031. Leptospirosis is a bacterial infection caused by the bacterium Leptospira. The bacterium is present in the kidneys of several mammals. When contaminated animal poo material is present in the soil and water, it spreads to humans through skin breaks such as cuts, open sores, or dry places. It spreads through the nose, mouth, and gen...
Report ID: 1872 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Pharmaceuticals